Your browser doesn't support javascript.
loading
SHIP1 inhibits cell growth, migration, and invasion in non­small cell lung cancer through the PI3K/AKT pathway.
Fu, Qiaofen; Huang, Yuhui; Ge, Chunlei; Li, Zhen; Tian, Hui; Li, Qiaolin; Li, Hongshuai; Li, Ruilei; Tao, Xingyu; Xue, Yuanbo; Wang, Ying; Yang, Guanqin; Fang, Weiyi; Song, Xin.
Afiliação
  • Fu Q; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Huang Y; Yunnan Tin Group Company Limited Institute of Labor Protection, Gejiu, Yunnan 661400, P.R. China.
  • Ge C; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Li Z; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Tian H; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Li Q; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Li H; Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Li R; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Tao X; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Xue Y; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Wang Y; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
  • Yang G; Medical Department of Yunnan Cancer Hospital, Kunming, Yunnan 650118, P.R. China.
  • Fang W; Cancer Center, Traditional Chinese Medicine­Integrated Hospital of Southern Medical University, Guangzhou, Guangdong 510310, P.R. China.
  • Song X; Department of Cancer Biotherapy Center, Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, P.R. China.
Oncol Rep ; 41(4): 2337-2350, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30720128
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Fosfatidilinositol-3,4,5-Trifosfato 5-Fosfatases / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Fosfatidilinositol-3,4,5-Trifosfato 5-Fosfatases / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article